This is the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...

The recent downturn in biotech has battered Massachusetts’ world-renowned sector, and the political climate has only made it ...

Merck won FDA approval for a shot that protects against RSV, the most common cause of hospitalization among infants ...

A bipartisan congressional report alleges that organ procurement organizations use a federal loophole to miscount the number ...

It scares me to think of what’s ahead,” said Michael Osterholm, director of the University of Minnesota’s Center for ...

One side of the vaccine debate is using us to score points. The other side is disregarding us entirely. Neither seems to be ...

Health Secretary Robert F. Kennedy Jr. has taken the extraordinary step of firing the expert panel that advises the CDC.

National Resilience, a startup that has raised over $2 billion by promising to transform drug manufacturing, said it would ...

The simplicity of Merck's monoclonal antibody for RSV in infants could be a plus in its competition with AstraZeneca's ...

A modern biomanufacturing ecosystem cannot rely on a handful of elite institutions or centralized research centers. HBCUs can ...

Republicans have faced pushback for their plans to pay for Trump’s tax cuts by reducing federal Medicaid funding and by ...

The NIH has rescinded a policy requiring recipients of new grants to certify they do not have unlawful DEI programs or ...